Acute Myeloid Leukemias M2, Potentially Misdiagnosed as M3 Variant French-American-Britain (FAB) Subtype: A Transitional Form?

References

• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposal for the classification of acute leukemias. French-American-British (FAB) Cooperative Group. Br. J. Haemat. 1986; 33: 451–458
   Web of Science ®Google Scholar
• Catovsky D., Matutes E., Buccheri V., Shetty V., Hanslip J., Yoshida N., Morilla R. A classification of acute leukemia for the 1990s. Ann. Hematol. 1991; 62: 16–21
   PubMed Web of Science ®Google Scholar
• Morphologic, immunologic and cytogenetic (MIC) working classification of the acute myeloid leukemias. Report of the Workshop in Leuven. Belgium, 15–17 Sept. 1986. II MIC Cooperative study Group. Br. J. Haemat. 1988; 68: 487–494
   PubMed Web of Science ®Google Scholar
• Warrell R. P., Jr., de Thé H., Wang Z. Y., Degas L. Acute promyelocytic leukemia. N. Engl. J. Med. 1993; 329: 177–189
   PubMed Web of Science ®Google Scholar
• Grignani F., Faggioli M., Alcalay M., Longo L., Pandolfi P. P., Donti E., Biondi Lo A., Coco F., Pelicci P. P. Acute promyelocytic leukemia: from genetics to treatment. Blood. 1994; 83: 10–25
   PubMed Web of Science ®Google Scholar
• Avvisati ten G., Cate J. W., Mandelli F. Acute Promyelocytic Leukemia. Br. J. Haemat. 1992; 81: 315–320
   PubMed Web of Science ®Google Scholar
• de Thé H., Chomienne C., Lanotte M., Degos L., Dejean A. The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor a gene to a novel transcribed locus. Nature 1990; 347: 558–561
   PubMed Web of Science ®Google Scholar
• Kakizuka A., Miller V. H., Jr., Umesono K., Warrell R. P., Jr., Frankel S. R., Murty V. V. V. S., Dmitrovsky E., Evans R. M. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARa with a novel putative transcription factor, PML. Cell 1991; 66: 663–674
   PubMed Web of Science ®Google Scholar
• de Thé H., Lavau C., Marchio A., Chomienne C., Degos L., Dejean A. The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 1991; 66: 675–67
   PubMed Web of Science ®Google Scholar
• Borrow J., Goddard A. D., Sheer D., Solomon E. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 1990; 249: 1577–1579
   PubMed Web of Science ®Google Scholar
• Biondi A., Rambaldi A., Alcalay M., Pandolfi Lo P. P., Coco F., Diverio D., Rossi V., Mencarelli A., Longo L., Zangrilli D., Masera G., Barbui T., Mandelli F., Grignani F., Pelicci P. G. RARα rearrangements as a genetic markers for diagnosis and monitoring in acute promyelocytic leukemia. Blood 1991; 77: 1418–1422
   PubMed Web of Science ®Google Scholar
• Lo Coco F., Diverio D., d'Adamo F., Avvisati G., Alimena G., Nanni M., Alcalay M., Pandolfi P. P., Pelicci P. G. PML/RARα rearrangement in acute promyelocytic leukemias apparently lacking the t(15;17) translocation. Eur. J. Haematol. 1992; 48: 173–176
   PubMed Web of Science ®Google Scholar
• Chen Z. X., Xue Y. Q., Zhang R., Tao R. F., Xia X. M., Li C., Wang W., Zu W. Y., Yao X. Z., Ling B. J. A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. Blood 1991; 78: 1413–1419
   PubMed Web of Science ®Google Scholar
• Castaigne S., Chomienne C., Daniel M. T., Ballerini P., Berger R., Fenaux P., Degos L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia, I. Clinical results. Blood 1990; 76: 1704–1709
   PubMed Web of Science ®Google Scholar
• Lo Coco F., Avvisati G., Diverio D., Petti M. C., Alcalay M., Pandolfi P. P., Zangrilli D., Biondi A., Ramhaldi A., Moleti M. L., Mandelli F., Pelicci P. G. Molecular evaluation of all trans retinoic acid therapy in patients with acute promyelocytic leukemia. Blood 1991; 77: 1657–1659
   PubMed Web of Science ®Google Scholar
• Chomienne C., Ballerini P., Balitrand Dani N., El Castaigne S M. T., Degos L. All trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship. Blood 1990; 76: 1710–1717
   PubMed Web of Science ®Google Scholar
• Warrell R. P., Frankel S. R., Miller W. H., Jr., Scheinherg D. A., Itri L. M., Hittelman W. N., Vyas R., Andreef M., Tafuri A., Jakuhowski A., Gabrilove J., Gordon M. S., Dimitrowsky E. Differentiation therapy of acute promyelocytic leukemia with trenitoin (all trans retinoic acid). New Eng. J. Med. 1991; 324: 1385–1393
   PubMed Web of Science ®Google Scholar
• Breitman T. R., Selonick S. E., Collins S. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA 1980; 77: 2936–2940
   PubMed Web of Science ®Google Scholar
• Golomb H. M., Rowley J. A., Vardinas J. W., Testa J. R., Butler A. “Microgranular” acute promyelocytik leukemia: a distinct clinical, ultrastructural and cytogenetic entity. Blood 1980; 55: 253–259
   PubMed Web of Science ®Google Scholar
• Davey F. R., Davis R. B., Mac Callum J. M. Morphologic and cytochemical characteristics of acute promyelocytic leukemia. Am. J. Hematol. 1989; 30: 221–227
   PubMed Web of Science ®Google Scholar
• Hayhoe F. G. J., Quaglino D. Hematological chemistry. Churchill-Livingstone., Edinburgh 1988
   Google Scholar
• Willman C. L. Flow cytometric analysis of hematologic specimens. Neoplastic Hematopathology, D. M. Knowles. Baltimore MD, Williams and Wilkins 1992; 169
   Google Scholar
• Foucar K., Chen I-M., Crago S. Organization of a flow cytometric immunophenotyping laboratory. Semin. Diagn. Pathol 1980; 6: 13–15
   Google Scholar
• Mitelman F. ISCN. Guidelines for Cancer Cytogenetics. Supplement to An International System for Human Cytogenetic Nomenclature, (Basel, 1991), S. Karger, 1991
   Google Scholar
• Wiegant J., Ried T., Nederlof P. M., van der Ploeg Mi., Tanke H. J., Raap A. K. In situ suppression hybridization with fluoresceinated DNA. Nucleic. Acid Res. 1991; 19: 3237–3241
   PubMed Web of Science ®Google Scholar
• Sambrook J., Fritsch E. F., Maniatis T. Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory, NY 1989
   Google Scholar
• Biondi A., Rambaldi A., Pandolfi P. P. Molecular monitoring of the PML/RARa fusion gene in acute promyelocytic leukemia by polymerase chain reaction. Blood 1992; 86: 492–497
   Google Scholar
• Krause J. R., Stolc V., Kaplan S. S., Penchansky L. Microgranular promyelocytic leukemia: a multiparameter examination. Am. J. Haemat. 1989; 30: 158–163
   PubMed Web of Science ®Google Scholar
• Quaglino D., De Pasquale A. Conventional cytochemistry, immunocytochemistry and their relationship to other cytobiological techniques in the clinical study of haematological diseases. Haematologica. 1988; 73: 143–152
   PubMedGoogle Scholar
• Das Gupta A., Sapre R. S., Shah A. S., Advani S. H., Nair C N. Cytochemical and immunophenotypic heterogeneity in acute promyelocitic leukemia. Acta Haemat. 1989; 81: 5–9
   PubMed Web of Science ®Google Scholar
• Tomonaga M., Yoshida Y., Tagawa M., Jinnai I., Kuriyama K., Amenomori T., Yoahioka A., Matsuo T., Nonaka H., Ichimaru M. Cytochemistry of acute promyelocytic leukemia (M3): leukemic promyelocytes exhibit heterogeneous patterns in cellular differentiation. Blood 1985; 66: 350–357
   PubMed Web of Science ®Google Scholar
• McKenna R. W., Parkin J., Bloomfield C. D., Sundberg R. D., Brunning R. D. Acute promyelocytic leukemia: a study of 39 cases with identification of a hyperhasophilic microgranular variant. Br. J. Haemat. 1982; 50: 201–204
   PubMed Web of Science ®Google Scholar
• Tallman M. S., Hakimian D., Snowen D., Rubin C. M., Reisel H., Variakojis D. Basophilic differentiation in acute promyelocytic leukemia. Leukemia 1993; 4: 521–526
   Google Scholar
• Invernizzi R., Iannone A. M., Bernuzzi S., d'Alessio A., Fiammenghi C., Ippoliti G. B., Scagliosi S., Ascari E. Acute promyelocytic leukemia: morphological and clinical features. Haematologica 1993; 78: 156–161
   PubMedGoogle Scholar
• Scott C. S., Patel D., Drexler H. G., Master P. T., Limbert J., Roberts E. Immunophenotypic and enzymatic studies do not support the concept of mixed monocytic-granulocytic differentiation in acute promyelocytic leukemia (M3): a study of 44 cases. Br. J. Haemat. 1989; 71: 505–509
   PubMed Web of Science ®Google Scholar
• DeRossi G., Avvisati G., Coluzzi S., Fenu Lo S., Coco F., Lopez M., Nanni M., Pasqualetti D., Mandelli F. Immunological definition of acute promyelocytic leukemia (FAB M3): a study ot 39 cues. Eur. J. Haematol. 1990; 45: 168–171
   PubMed Web of Science ®Google Scholar
• Krause J. R., Stolc V., Kaplan S. S., Penchansky L. Microgranular promyelocytic leukemia: a multiparameter examination. Am. J. Haemat. 1989; 30: 158–163
   PubMed Web of Science ®Google Scholar
• Lano E., Medina J., Ramirez Garcia A., Gala J., Rosbn C., Martinez A. Acute promyelocytic leukemia (APL): ultra-structure in 24 cases. International Symposium “Acute Promyelocytic Leukemia: a curable disease?”. Rome November 11–12, 1993; 22, Abstract Book
   Google Scholar
• Castoldi G. I., Liso V. Acute promyelocytic leukemia: morphological aspects. International Symposium “Acute Promyelocytic Leukemia: a curable disease?”. Rome November 11–12, 1993; 5, Abstract Book
   Google Scholar
• Karakantza M., Bevan D. H., Ball S. E. Lack of PML/rara rearrangement in ATRA non-responders. International Symposium “Acute Promyelocytic Leukemia: a curable disease?”. Rome November 11–12, 1993; 61, Abstract Book
   Google Scholar
• Biondi A., Luciano A., Bassan R., Minimi D., Specchia G., Lanzi E., Castapna S., Rajnoldi A. C., Liso V., Masera G., Barbui T., Ramholdi A. CD2 expression correlates with microgranuiar acute prornyelocytic leukemia (M3v) and not with PML gene breakpoint. International Symposium “acute Promyelocytic Leukemia curable disease?”. Rome November 11–12, 1993; 28, Abstract Book
   Google Scholar
• Scott A. A., Head D: R., Kopecky K. J., Appelbaum F. R., Theil K., Grew-S M. R., Chen I. M., Whittaker M. H., Griffith B. B., Licht J. D., Waxman S., Whalen M. M., Bankhurst A. D., Richter L. C., Grogan T. M., Willman C. L. HLA-DR−, CD33+, CD56+. CD 16 Myeloid/Natural killer cell acute Leukemia: a previosly unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia- M3. Blood, 84: 244–255
   PubMed Web of Science ®Google Scholar